DUBLIN, Jan. 3, 2024 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) announced today that its Chief Executive Officer,
Richard Pops, will provide a
corporate overview and update at the 42nd Annual J.P.
Morgan Healthcare Conference. The presentation will take place on
Wednesday, Jan. 10, 2024 at
11:15 a.m. PST (2:15 p.m. EST/7:15 p.m.
GMT), followed by a question and answer session. The live
webcast may be accessed under the Investors tab on
www.alkermes.com and will be archived for 14 days.
About Alkermes plc
Alkermes plc is a global
biopharmaceutical company that seeks to develop innovative
medicines in the field of neuroscience. The company has a portfolio
of proprietary commercial products for the treatment of alcohol
dependence, opioid dependence, schizophrenia and bipolar I
disorder, and a pipeline of clinical and preclinical candidates in
development for neurological disorders. Headquartered in
Dublin, Ireland, Alkermes has
a research and development center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Jamie Constantine
Investor Relations
+1 781 873 2402
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/alkermes-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302025519.html